INSPECS Group (SPEC) Competitors GBX 42 -1.50 (-3.45%) (As of 07:11 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades SPEC vs. BVC, AKR, CNSL, ODX, CTEC, AMS, TSTL, BXP, AVCT, and 4BBShould you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include BATM Advanced Communications (BVC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Tristel (TSTL), Beximco Pharmaceuticals (BXP), Avacta Group (AVCT), and 4basebio (4BB). These companies are all part of the "medical" sector. INSPECS Group vs. BATM Advanced Communications Akers Biosciences Cambridge Nutritional Sciences Omega Diagnostics Group ConvaTec Group Advanced Medical Solutions Group Tristel Beximco Pharmaceuticals Avacta Group 4basebio INSPECS Group (LON:SPEC) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, community ranking, analyst recommendations, media sentiment, profitability, earnings, dividends and risk. Which has stronger earnings and valuation, SPEC or BVC? BATM Advanced Communications has lower revenue, but higher earnings than INSPECS Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINSPECS Group£195.14M0.22-£4.11M-£3.07-13.68BATM Advanced Communications£122.70M0.66£2.51MN/AN/A Which has more risk and volatility, SPEC or BVC? INSPECS Group has a beta of 2.22, indicating that its stock price is 122% more volatile than the S&P 500. Comparatively, BATM Advanced Communications has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. Does the media refer more to SPEC or BVC? In the previous week, INSPECS Group had 5 more articles in the media than BATM Advanced Communications. MarketBeat recorded 5 mentions for INSPECS Group and 0 mentions for BATM Advanced Communications. INSPECS Group's average media sentiment score of 0.51 beat BATM Advanced Communications' score of 0.00 indicating that INSPECS Group is being referred to more favorably in the media. Company Overall Sentiment INSPECS Group Positive BATM Advanced Communications Neutral Do insiders and institutionals have more ownership in SPEC or BVC? 67.8% of INSPECS Group shares are owned by institutional investors. Comparatively, 42.4% of BATM Advanced Communications shares are owned by institutional investors. 25.6% of INSPECS Group shares are owned by insiders. Comparatively, 26.2% of BATM Advanced Communications shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer SPEC or BVC? BATM Advanced Communications received 185 more outperform votes than INSPECS Group when rated by MarketBeat users. However, 100.00% of users gave INSPECS Group an outperform vote while only 49.48% of users gave BATM Advanced Communications an outperform vote. CompanyUnderperformOutperformINSPECS GroupOutperform Votes5100.00% Underperform VotesNo VotesBATM Advanced CommunicationsOutperform Votes19049.48% Underperform Votes19450.52% Is SPEC or BVC more profitable? BATM Advanced Communications has a net margin of -0.21% compared to INSPECS Group's net margin of -2.11%. BATM Advanced Communications' return on equity of -0.17% beat INSPECS Group's return on equity.Company Net Margins Return on Equity Return on Assets INSPECS Group-2.11% -3.95% 0.45% BATM Advanced Communications -0.21%-0.17%0.58% Is SPEC or BVC a better dividend stock? INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 2.4%. BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 5.4%. INSPECS Group pays out -32.6% of its earnings in the form of a dividend. SummaryBATM Advanced Communications beats INSPECS Group on 9 of the 16 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get INSPECS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPEC vs. The Competition Export to ExcelMetricINSPECS GroupMedical Instruments & Supplies IndustryMedical SectorLON ExchangeMarket Cap£42.70M£2.54B£5.25B£1.41BDividend Yield2.00%2.01%5.12%11.72%P/E Ratio-13.68334.55135.511,570.93Price / Sales0.22206.871,231.37317,288.46Price / Cash1.63124.3035.5732.92Price / Book0.422.614.822.86Net Income-£4.11M£84.03M£119.12M£152.61M7 Day Performance-13.45%0.90%1.51%4.38%1 Month Performance-31.71%-2.04%-0.56%9.25%1 Year Performance-50.00%-2.05%33.09%92.56% INSPECS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPECINSPECS GroupN/AGBX 42-3.4%N/A-47.6%£42.70M£195.14M-13.681,673Gap UpBVCBATM Advanced CommunicationsN/AGBX 18.90+7.0%N/A-9.3%£82.44M£122.70M2,800.00980AKRAkers BiosciencesN/AGBX 57.50flatN/AN/A£21.64M£2.32M-0.44120CNSLCambridge Nutritional SciencesN/AGBX 3+0.1%N/A+14.3%£7.15M£9.77M-362.103,200Gap UpODXOmega Diagnostics GroupN/AGBX 2.20flatN/A+0.0%£5.23M£7.55M-220.0091Gap DownCTECConvaTec Group2.5217 of 5 starsGBX 236.22+0.6%GBX 301.67+27.7%+3.1%£4.84B£2.20B3,913.3310,000AMSAdvanced Medical Solutions Group2.3266 of 5 starsGBX 208+0.5%GBX 300+44.2%+7.9%£446.26M£131.11M4,140.0010Gap DownTSTLTristelN/AGBX 384.40+5.3%N/A-13.3%£183.17M£39.49M2,807.69208High Trading VolumeBXPBeximco PharmaceuticalsN/AGBX 36.98+0.5%N/A-15.7%£164.97M£43.08B450.005,500News CoverageAVCTAvacta GroupN/AGBX 45.10-2.0%N/A-65.7%£161.59M£22.62M-511.111204BB4basebioN/AGBX 1,256.50+0.4%N/A+80.2%£160.96M£311,000.00-1,666.67101Gap Down Related Companies and Tools Related Companies BVC Alternatives AKR Alternatives CNSL Alternatives ODX Alternatives CTEC Alternatives AMS Alternatives TSTL Alternatives BXP Alternatives AVCT Alternatives 4BB Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SPEC) was last updated on 12/12/2024 by MarketBeat.com Staff From Our PartnersEx-Lawyer turns $50k into $5 million tradingHe was a lawyer by day, secret trader by night...or in this case by lunch… With nothing but a laptop and a ...Investing Daily | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredPrepare Now Before This Looming $2 Trillion D.C. ShockMillions of traders could get blindsided by this election-year shock on December 18th… And if you do nothin...Timothy Sykes | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredVance Exposes Wall Street Plan to Crash Bonds, Target TrumpJ.D. Vance just dropped a bombshell: With Trump in office, Wall Street could drive the bond market into a deat...Golden Crest | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INSPECS Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share INSPECS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPEC Stock Alerts